Donor country official development assistance in health R&D: domestic economic burden vs. medical disseminative capacity.

This study investigates the domestic factors influencing official development assistance (ODA) allocated by donor countries specifically for health research and development (R&D). It finds that health R&D ODA is negatively affected by a donor country’s domestic economic burden—measured by indicators such as GDP per capita, unemployment, debt, and current account deficits—while positively associated with the country’s medical disseminative capacity (MDC), defined as its global influence in medicine through clinical trials, pharmaceutical export strength, and participation in international health forums. Using panel data from forty-four donor countries between 2016 and 2021, the analysis shows that although economic pressures reduce overall health R&D ODA, countries with higher MDC tend to maintain or increase their health R&D ODA and its share relative to total ODA. The study highlights the interplay between inward-looking economic constraints and outward-looking scientific influence in shaping donor health R&D aid, offering implications for policymakers, medical research communities, and recipient countries seeking funding.